DocGo (DCGO) TD Cowen 46th Annual Health Care Conference summary

Business overview and strategy

• Delivers technology-enabled mobile healthcare and medical transport, serving major hospital systems and insurers in the US and UK.

• Operates nearly 1,000 vehicles and employs over 3,000 clinical staff, providing care at scale with over 10 million patients served to date.

• Focuses on proactive, in-home care to reduce unnecessary hospital visits and improve patient outcomes, with a Net Promoter Score above 92.

• All patient referrals come from hospital and insurance partners, not direct-to-consumer advertising.

• Vertical integration includes owning licensure, fleet, tech stack, lab license, clinical practice group, and managed care credentials.

Financial performance and outlook

• 2026 revenue guidance is $280–$300 million, excluding COVID- or migrant-related contracts.

• Q3 last year saw $71 million in revenue, with $50 million from medical transportation and $20 million from mobile health.

• No outstanding debt, $95 million cash on hand at end of Q3, and expects to exit the year at a break-even profitable run rate.

• Adjusted EBITDA loss for the year is projected at -$15 to -$25 million, with all service lines at record volume.

Service offerings and operational model

• Provides medical transportation, in-home care, remote patient monitoring, and telehealth, with over 1 million telehealth visits and 2 million lab orders last year.

• Uses a tech-enabled model where licensed practical nurses visit homes, supported remotely by advanced providers via telehealth.

• Acquired SteadyMD to expand advanced provider network and telehealth capabilities, adding $25 million in revenue and expected to be EBITDA positive.

• Reduces hospital readmissions by 60% for high-risk patients, and manages over 700,000 medical transports annually.